Aehr Test Systems provides earnings guidance for the fiscal year ending May 31, 2024. For the period, the company reiterating its previously provided guidance for total revenue of greater than $65 million and GAAP net income of approximately $11 million or more, or $0.38 per diluted share.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
11.76 USD | +0.26% | +5.57% | -55.67% |
Apr. 10 | Sector Update: Tech Stocks Decline Premarket Wednesday | MT |
Apr. 10 | Aehr Swings to Fiscal Q3 Non-GAAP Loss, Revenue Drops; Shares Decline Premarket | MT |
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-55.67% | 339M | |
+12.82% | 113B | |
+38.63% | 103B | |
+9.63% | 19.64B | |
+5.66% | 18.59B | |
+39.48% | 9.93B | |
+28.00% | 9.11B | |
-4.84% | 7.47B | |
-23.07% | 6.13B | |
+36.51% | 5.21B |
- Stock Market
- Equities
- AEHR Stock
- News Aehr Test Systems
- Aehr Test Systems Provides Earnings Guidance for the Fiscal Year Ending May 31, 2024